Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PBH

PBH - Prestige Consumer Healthcare Inc Stock Price, Fair Value and News

$63.11-0.79 (-1.24%)
Market Closed

52/100

PBH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

52/100

PBH

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$65.21

Target 3M

$65.67

Target 6M

$65.47

PBH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PBH Price Action

Last 7 days

-5.8%

Last 30 days

-0.9%

Last 90 days

4.7%

Trailing 12 Months

-20.5%

PBH RSI Chart

PBH Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PBH Valuation

Market Cap

3.0B

Price/Earnings (Trailing)

15.11

Price/Sales (Trailing)

2.73

EV/EBITDA

-26.44

Price/Free Cashflow

11.88

PBH Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$65.21

Target 3M

$65.67

Target 6M

$65.47

PBH Fundamentals

PBH Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

-3.41%

Rev. Growth (Qtr)

9.85%

PBH Earnings

Earnings (TTM)

200.8M

Earnings Growth (Yr)

-22.37%

Earnings Growth (Qtr)

-11.07%

PBH Profitability

Operating Margin

56.10%

EBT Margin

-8.46%

Return on Equity

11%

Return on Assets

5.83%

Free Cashflow Yield

8.42%

PBH Investor Care

Buy Backs (1Y)

2.67%

Diluted EPS (TTM)

4.04

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.1B1.1B1.1B0
20241.1B1.1B1.1B1.1B
20231.1B1.1B1.1B1.1B
20221.1B1.1B1.1B1.1B
2021943.4M983.2M1.0B1.1B
2020963.0M960.3M959.6M956.8M
2019975.8M954.0M952.7M952.8M
20181.0B1.0B1.0B990.7M
2017882.1M929.1M972.0M1.0B
2016806.2M823.7M832.7M849.2M
2015714.6M761.1M785.8M788.4M
2014597.4M600.6M614.9M667.6M
2013623.6M619.1M624.2M608.8M
2012441.1M492.8M549.1M603.1M
2011333.7M357.8M385.0M400.7M
2010000323.4M
Get all data in R, Python etc through our Historical Stock Data APIs

About Prestige Consumer Healthcare Inc

PBH
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
 CEO
 WEBSITEprestigebrands.com
 SECTORHealthcare
 INDUSTRYDrug Manufacturers Specialty & Generic
 EMPLOYEES560

Prestige Consumer Healthcare Inc Frequently Asked Questions

PBH is the stock ticker symbol of Prestige Consumer Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Prestige Consumer Healthcare Inc is 3.03 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check PBH's fair value in chart for subscribers.

The fair value guage provides a quick view whether PBH is over valued or under valued. Whether Prestige Consumer Healthcare Inc is cheap or expensive depends on the assumptions which impact Prestige Consumer Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PBH.

As of Wed Jan 28 2026, PBH's PE ratio (Price to Earnings) is 15.11 and Price to Sales (PS) ratio is 2.73. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PBH PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Prestige Consumer Healthcare Inc has provided 0.031 (multiply by 100 for percentage) rate of return.